Please log in to save bookmarks. Only registered users can save their favorite pages.
Journal Properties
Number of Articles
639
Abbreviation
J Bioequivalence Bioavailability
e-ISSN
0975-0851
Publisher
OMICS Publishing Group
Indian UGC
DOAJ (latest)
Description
The Journal of Bioequivalence & Bioavailability is a dedicated forum for disseminating research focused on drug development, formulation, and therapeutic efficacy. The journal aims to provide insights into how different formulations of the same drug, or different drugs with similar pharmacological effects, compare in terms of bioavailability and bioequivalence. The core focus is to support the development of generic drugs and improve drug delivery systems.
Key topics covered in this journal include pharmacokinetic and pharmacodynamic studies, comparative bioavailability assessments, and factors influencing drug absorption, distribution, metabolism, and excretion (ADME). It also highlights the role of drug formulation in achieving desired therapeutic outcomes, exploring novel drug delivery systems, and optimizing existing formulations. This journal is a valuable resource for pharmaceutical scientists, regulatory professionals, and researchers involved in drug development and generic drug approval processes. It encourages contributions related to clinical trials, in vitro-in vivo correlations, and regulatory aspects of bioequivalence studies.
With its focus on drug performance, this journal seeks to foster innovation, encourage rigorous scientific investigation, and promote the development of safe and effective pharmaceuticals. It encourages the submission of original research that advances the field and enhances the understanding of drug behavior in the human body.